Research Summaries

FDA Alert
FDA Alert
11/13/2023
Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.
11/13/2023
FDA Alert
FDA Alert
08/10/2023
Jessica Ganga
The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.
08/10/2023
Research Summary
Research Summary
04/17/2023
Researchers set out to determine the percentage of people in the United States with type 2 diabetes who meet the recommended criteria to use GLP-1 receptor agonists and SGLT-2 inhibitors as well as patients...
04/17/2023
Research Summary
Research Summary
02/28/2023
The researchers evaluated the effects of two medications used for type 2 diabetes patients on reducing major cardiovascular events in both men and women.
02/28/2023
Non-Diabetic Kidney Disease
Non-Diabetic Kidney Disease
01/06/2023
Researchers found a high prevalence of kidney disease in patients with type 2 diabetes mellitus from causes other than diabetes.
01/06/2023
Global Health
Global Health
12/29/2022
The researchers aimed to determine the global burden and rise of type 2 diabetes across the globe in adolescents and young adults.
12/29/2022
Disease Management
Disease Management
12/14/2022
The Endocrine Society released an updated list of guidelines and recommendations to help clinicians and patients with diabetes manage hypoglycemia.
12/14/2022
Research Summary
rs
Research Summary
12/09/2022
Researchers distinguish specific risk factors that may predict who is at risk for developing diabetes if they have chronic pancreatitis.
12/09/2022
Conference Coverage
Conference Coverage
11/18/2022
Emerging treatments have improved the standard of care for managing patients with both type 2 diabetes and obesity. Carol Wysham, MD, and Deborah B. Horn, DO, MPH, discuss these new treatments and...
11/18/2022
Conference Coverage
Conference Coverage
11/18/2022
This article summarized a presentation on individualized treatment and medication prescribing for patients with type 2 diabetes by Kathryn Evans Kreider, DNP, at the Practical Updates in Primary Care 2022...
11/18/2022